¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2018 ´ëÇÑ´ëÀåÇ×¹®ÇÐȸ Ç׾Ͽä¹ý¿¬±¸È¸ ¿öÅ©¼¥ : 2018-11-09

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
2018 ´ëÇÑ´ëÀåÇ×¹®ÇÐȸ Ç׾Ͽä¹ý¿¬±¸È¸ ¿öÅ©¼¥ : 2018-11-09
±³À°ÀÏÀÚ : 2018-11-09
±³À°Àå¼Ò : °í·Á´ëÇб³ ¾È»êº´¿ø 2Ãþ ´ë°­´ç  
±³À°ÁÖÁ¦ : 2018 ´ëÇÑ´ëÀåÇ×¹®ÇÐȸ Ç׾Ͽä¹ý¿¬±¸È¸ ¿öÅ©¼¥ 
ÁÖÃÖ±â°ü : ´ëÇÑ´ëÀåÇ×¹®ÇÐȸ
´ã´çÀÚ : ÃÖÇý¿ø
¿¬¶ôó : 02-2040-7737  
À̸ÞÀÏ : colon7737@kams.or.kr      
±³À°Á¾·ù : ¿Ü°úÀÇÇб³À°
Âü¼®¿¹»óÀοø : 50¸í
Èñ¸ÁÆòÁ¡ : 5Á¡  
Áö¿ª : °æ±âµµ
±³À°½Ã°£ : 5 ½Ã°£ 10ºÐ  
¼¼ºÎ¼ö°­·á : 10,000¿ø      
ºñ°í       

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11-09 °í·Á´ëÇб³ ¾È»êº´¿ø 2Ãþ ´ë°­´ç 10:00~10:15 AJCC cancer staging 8th ed. for Colon and Rectal Cancer  ¾Èżº(¼øõÇâÀÇ´ë) 
±³À°½Ã°£ 11-09 °í·Á´ëÇб³ ¾È»êº´¿ø 2Ãþ ´ë°­´ç 10:15~10:30 Clinical significance of lymph node micrometastasis in colorectal cancer  È«±¤´ë (°í·ÁÀÇ´ë ) 
±³À°½Ã°£ 11-09 °í·Á´ëÇб³ ¾È»êº´¿ø 2Ãþ ´ë°­´ç 10:30~10:45 Do we need chemotherapy in low risk patients of stage II colon cancer?   ¹è¼º¿í(°è¸íÀÇ´ë) 
±³À°½Ã°£ 11-09 °í·Á´ëÇб³ ¾È»êº´¿ø 2Ãþ ´ë°­´ç 10:45~11:00 Management for geriatric patients with colorectal cancer  ÀÌÀαÔ(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 11-09 °í·Á´ëÇб³ ¾È»êº´¿ø 2Ãþ ´ë°­´ç 11:00~11:15 Oxaliplatin-based adjuvant chemotherapy : Choice and duration  Áö¿õ¹è (°í·ÁÀÇ´ë ) 
±³À°½Ã°£ 11-09 °í·Á´ëÇб³ ¾È»êº´¿ø 2Ãþ ´ë°­´ç 11:15~11:30 Neoadjuvant chemotherapy for locally advanced colon cancer  ¹Ú¼ö¿¬(°æºÏÀÇ´ë) 
±³À°½Ã°£ 11-09 °í·Á´ëÇб³ ¾È»êº´¿ø 2Ãþ ´ë°­´ç 11:30~11:45 Cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy  ¹é½ÂÇõ(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 11-09 °í·Á´ëÇб³ ¾È»êº´¿ø 2Ãþ ´ë°­´ç 11:45~12:00 Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC)  ÀÌÀ±ÅÃ(°í·ÁÀÇ´ë) 
½Ä»ç 11-09 °í·Á´ëÇб³ ¾È»êº´¿ø 2Ãþ ´ë°­´ç 12:00~13:00 Friends I met in Camino  ÀÌ ¼® ȯ(°æÈñÀÇ´ë) 
±³À°½Ã°£ 11-09 °í·Á´ëÇб³ ¾È»êº´¿ø 2Ãþ ´ë°­´ç 13:00~13:15 Optimal interval to surgery after preoperative CCRT in rectal cancer  ¹é¼º±Ô(°è¸íÀÇ´ë) 
±³À°½Ã°£ 11-09 °í·Á´ëÇб³ ¾È»êº´¿ø 2Ãþ ´ë°­´ç 13:15~13:30 Treatment Strategies for cT1/ or pT1 in very low-lying rectal cancer  °­¼º¹ü(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 11-09 °í·Á´ëÇб³ ¾È»êº´¿ø 2Ãþ ´ë°­´ç 13:30~13:45 Do we still need TME after preop CCRT?  ±èÈñö(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 11-09 °í·Á´ëÇб³ ¾È»êº´¿ø 2Ãþ ´ë°­´ç 13:45~14:00 Total neoadjuvant therapy for locally advanced rectal cancer  À̼®È¯(°æÈñÀÇ´ë) 
È޽Ġ11-09 °í·Á´ëÇб³ ¾È»êº´¿ø 2Ãþ ´ë°­´ç 14:00~14:20  Break  () 
±³À°½Ã°£ 11-09 °í·Á´ëÇб³ ¾È»êº´¿ø 2Ãþ ´ë°­´ç 14:20~14:35 Chemotherapy for resectable colorectal liver metastasis/ Best time for liver resection?  ¹Ú¼±Áø(°æÈñÀÇ´ë) 
±³À°½Ã°£ 11-09 °í·Á´ëÇб³ ¾È»êº´¿ø 2Ãþ ´ë°­´ç 14:35~14:50 Choice for 1st line Chemotherapy with Targeted Agent for potentially resectable CRLM  ¼Õ°æ¸ð(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 11-09 °í·Á´ëÇб³ ¾È»êº´¿ø 2Ãþ ´ë°­´ç 14:50~15:05 Choice for 2nd line Chemotherapy with Targeted Agent for metastatic colorectal cancer  ±èÁöÈÆ(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 11-09 °í·Á´ëÇб³ ¾È»êº´¿ø 2Ãþ ´ë°­´ç 15:05~15:20 Choice for 3rd line Chemotherapy with Targeted Agent for metastatic colorectal cancer  ¹è±â¹ü(ÀÎÁ¦ÀÇ´ë) 
È޽Ġ11-09 °í·Á´ëÇб³ ¾È»êº´¿ø 2Ãþ ´ë°­´ç 15:20~15:40  Break  () 
±³À°½Ã°£ 11-09 °í·Á´ëÇб³ ¾È»êº´¿ø 2Ãþ ´ë°­´ç 15:40~15:55  Surgery CASE I   .(.) 
±³À°½Ã°£ 11-09 °í·Á´ëÇб³ ¾È»êº´¿ø 2Ãþ ´ë°­´ç 15:55~16:05  Surgery CASE II   .(.) 
±³À°½Ã°£ 11-09 °í·Á´ëÇб³ ¾È»êº´¿ø 2Ãþ ´ë°­´ç 16:05~16:20  Surgery CASE III  .(.) 
±³À°½Ã°£ 11-09 °í·Á´ëÇб³ ¾È»êº´¿ø 2Ãþ ´ë°­´ç 16:20~16:35  Surgery CASE IV   .(.) 
±³À°½Ã°£ 11-09 °í·Á´ëÇб³ ¾È»êº´¿ø 2Ãþ ´ë°­´ç 16:35~16:50  Surgery CASE V   .(.) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2018 ´ëÇÑ´ëÀåÇ×¹®ÇÐȸ Ç׾Ͽä¹ý¿¬±¸È¸ ¿öÅ©¼¥ : 2018-11-09""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û Á¦49Â÷ ´ëÇÑ°íÇ÷¾ÐÇÐȸ Ãß°è±¹Á¦Çмú´ëȸ : 2018-11-09
´ÙÀ½±Û ´ëÇѳ»½Ã°æº¹°­°æ¿Ü°úÇÐȸ SMIT2018 - IBEC2018 Joint Conference : 2018-11-09
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20925 ÀüºÏ Á¦ 53Â÷ ´ëÇѳëÀκ´ÇÐȸ È£³²Áöȸ ÇмúÁý´äȸ : 2024-07-27 0 37 2024-05-28
20924 ¼­¿ï 2024 Á¦27ȸ ´ëÇѾȸ鼺ÇüÀç°ÇÇÐȸ Ãá°è Çмú´ëȸ : 2024-07-21 0 35 2024-05-28
20923 °æ±â 2024³â ÀÏ»ê¹éº´¿ø Á¤Çü¿Ü°ú ½ÉÆ÷Áö¾ö : 2024-07-21 0 31 2024-05-28
20922 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(2ÀÏÂ÷) : 2024-07-20 0 27 2024-05-28
20921 ¼­¿ï Á¦33Â÷ ´ç´¢º´ ¿¬±¸ ÇÏ°è¿öÅ©¼¥ : 2024-07-20 0 31 2024-05-28
20920 ¼­¿ï ´ëÇÑÁ¾¾ç³»°úÇÐȸ Recent updates in GU Cancers 2024 : 2024-07-19 0 47 2024-05-28
20919 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(1ÀÏÂ÷) : 2024-07-19 0 17 2024-05-28
20918 ¼­¿ï [¿Â¶óÀÎ] Áø´Ü¿ë ¹æ»ç¼± ¾ÈÀü°ü¸®Ã¥ÀÓÀÚ ¼±ÀÓ±³À° : 2024-07-14 0 25 2024-05-28
20917 °æºÏ 2024³â ´ëÇÑ°ñ´Ù°øÁõÇÐȸ ¿µ³² ¿¬¼ö°­Á : 2024-07-14 0 24 2024-05-28
20916 °æ±â ÀÎÁ¦´ëÇб³ ÀÏ»ê¹éº´¿ø ¼ÒÈ­±â³»°ú °³¿øÀÇ ¿¬¼ö°­Á : 2024-07-13 0 24 2024-05-28
20915 °æ±â 2024³â ÀÇÁ¤ºÎÀ»Áö´ëÇб³º´¿ø Á¦1ȸ ½Å°æ°ú °³¿øÀÇ ¿¬¼ö±³À° : 2024-07-13 0 22 2024-05-28
20914 ºÎ»ê Á¦6ȸ ºÎ»ê¼º¸ðº´¿ø ¼Ò¾Æû¼Ò³â°ú ½ÉÆ÷Áö¾ö : 2024-07-13 0 20 2024-05-28
20913 ¼­¿ï 2024 ´ëÇѽŰ泻ºÐºñ¿¬±¸È¸ ¿¬¼ö°­Á : 2024-07-13 0 23 2024-05-28
20912 ¼­¿ï ÀºÆò±¸ÀÇ»çȸ Á¦3Â÷¿¬¼ö±³À° : 2024-07-11 0 28 2024-05-28
20911 ¼­¿ï (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-08 0 28 2024-05-28
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷